This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Blagosklonny, M. V. Articles by Neckers, L. Search for Related Content PubMed PubMed Citation Articles by Blagosklonny, M. V. Articles by Neckers, L.

Taxol Induction of p21^WAF1 and p53 Requires c-raf-1

Clinical Pharmacology Branch [M. V. B., T. W. S., E. G. M., L. N.] and Medicine Branch [P. N., J. T.], National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892

Taxol stabilizes microtubules, prevents tubulin depolymerization, and promotes tubulin bundling and is one of the most effective drugs for the treatment of metastatic breast and ovarian cancer. Although its interaction with tubulin has been well characterized, the mechanism by which taxol induces growth arrest and cytoxicity is not well understood. Herein, we show that taxol induced dose- and time-dependent accumulation of the cyclin inhibitor p21^WAF1 in both p53 wild-type and p53-null cells, although the degree of induction was greater in cells expressing wild-type p53. In MCF7 cells, wild-type p53 protein was also induced after taxol treatment, and this induction was mediated primarily by increased protein stability. Taxol induced both p21^WAF1 and wild-type p53 optimally in MCF7 cells after 20–24-h exposure with an EC₅₀³ of 5 nM. In p53-null PC3M cells, p21^WAF1 was similarly induced after 24-h exposure to taxol. Coincident with these biochemical effects, taxol altered the electrophoretic mobility of c-raf-1 and stimulated mitogen activated protein kinase. Previous depletion of c-raf-1 inhibited both the p21^WAF1- and p53-inducing properties of taxol, as well as the activation of MAP kinase. These data suggest that induction of p21^WAF1 by taxol requires c-raf-1 activity, but that it is not strictly dependent on wild-type p53. Furthermore, the ability of taxol to both induce wild-type p53 in MCF7 cells and activate MAP kinase is also dependent on c-raf-1 expression.

¹ To whom requests for reprints should be addressed, at Building 10, Room 12N226, Clinical Pharmacology Branch, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892. Phone: (301) 402-3308; Fax: (301) 402-1608; E-mail: lenhelix.nih.gov.

Received 7/12/95. Accepted 8/15/95.

This article has been cited by other articles:

				E. Azambuja, V. Durbecq, D. D. Rosa, M. Colozza, D. Larsimont, M. Piccart-Gebhart, and F. Cardoso HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer Ann. Onc., February 1, 2008; 19(2): 223 - 232. [Abstract] [Full Text] [PDF]

				J.-S. Kim, Y.-C. Lee, H.-T. Nam, G. Li, E.-J. Yun, K.-S. Song, K.-S. Seo, J.-H. Park, J.-W. Ahn, O. Zee, et al. Apicularen A Induces Cell Death through Fas Ligand Up-Regulation and Microtubule Disruption by Tubulin Down-Regulation in HM7 Human Colon Cancer Cells Clin. Cancer Res., November 1, 2007; 13(21): 6509 - 6517. [Abstract] [Full Text] [PDF]

				J.-P. Liou, K.-S. Hsu, C.-C. Kuo, C.-Y. Chang, and J.-Y. Chang A Novel Oral Indoline-Sulfonamide Agent, N-[1-(4-Methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-Isonicotinamide (J30), Exhibits Potent Activity against Human Cancer Cells in Vitro and in Vivo through the Disruption of Microtubule J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 398 - 405. [Abstract] [Full Text] [PDF]

				A. N. Shajahan, A. Wang, M. Decker, R. D. Minshall, M. C. Liu, and R. Clarke Caveolin-1 Tyrosine Phosphorylation Enhances Paclitaxel-mediated Cytotoxicity J. Biol. Chem., February 23, 2007; 282(8): 5934 - 5943. [Abstract] [Full Text] [PDF]

				J. K. Hess-Wilson, H. K. Daly, W. A. Zagorski, C. P. Montville, and K. E. Knudsen Mitogenic Action of the Androgen Receptor Sensitizes Prostate Cancer Cells to Taxane-Based Cytotoxic Insult Cancer Res., December 15, 2006; 66(24): 11998 - 12008. [Abstract] [Full Text] [PDF]

				J. Gong, D. Yang, S. Kohanim, R. Humphreys, L. Broemeling, and R. Kurzrock Novel in vivo imaging shows up-regulation of death receptors by paclitaxel and correlates with enhanced antitumor effects of receptor agonist antibodies Mol. Cancer Ther., December 1, 2006; 5(12): 2991 - 3000. [Abstract] [Full Text] [PDF]

				S. C. Dowdy, S. Jiang, X. C. Zhou, X. Hou, F. Jin, K. C. Podratz, and S.-W. Jiang Histone deacetylase inhibitors and paclitaxel cause synergistic effects on apoptosis and microtubule stabilization in papillary serous endometrial cancer cells. Mol. Cancer Ther., November 1, 2006; 5(11): 2767 - 2776. [Abstract] [Full Text] [PDF]

				J. Halder, C. N. Landen Jr., S. K. Lutgendorf, Y. Li, N. B. Jennings, D. Fan, G. M. Nelkin, R. Schmandt, M. D. Schaller, and A. K. Sood Focal Adhesion Kinase Silencing Augments Docetaxel-Mediated Apoptosis in Ovarian Cancer Cells Clin. Cancer Res., December 15, 2005; 11(24): 8829 - 8836. [Abstract] [Full Text] [PDF]

				G. Kuznetsov, M. J. Towle, H. Cheng, T. Kawamura, K. TenDyke, D. Liu, Y. Kishi, M. J. Yu, and B. A. Littlefield Induction of Morphological and Biochemical Apoptosis following Prolonged Mitotic Blockage by Halichondrin B Macrocyclic Ketone Analog E7389 Cancer Res., August 15, 2004; 64(16): 5760 - 5766. [Abstract] [Full Text] [PDF]

				C.-C. Kuo, H.-P. Hsieh, W.-Y. Pan, C.-P. Chen, J.-P. Liou, S.-J. Lee, Y.-L. Chang, L.-T. Chen, C.-T. Chen, and J.-Y. Chang BPR0L075, a Novel Synthetic Indole Compound with Antimitotic Activity in Human Cancer Cells, Exerts Effective Antitumoral Activity in Vivo Cancer Res., July 1, 2004; 64(13): 4621 - 4628. [Abstract] [Full Text] [PDF]

				Z. P. Lin, M. F. Belcourt, J. G. Cory, and A. C. Sartorelli Stable Suppression of the R2 Subunit of Ribonucleotide Reductase by R2-targeted Short Interference RNA Sensitizes p53(-/-) HCT-116 Colon Cancer Cells to DNA-damaging Agents and Ribonucleotide Reductase Inhibitors J. Biol. Chem., June 25, 2004; 279(26): 27030 - 27038. [Abstract] [Full Text] [PDF]

				J.-Y. Chang, C.-Y. Chang, C.-C. Kuo, L.-T. Chen, Y.-S. Wein, and Y.-H. Kuo Salvinal, a Novel Microtubule Inhibitor Isolated from Salvia miltiorrhizae Bunge (Danshen), with Antimitotic Activity in Multidrug-Sensitive and -Resistant Human Tumor Cells Mol. Pharmacol., January 1, 2004; 65(1): 77 - 84. [Abstract] [Full Text] [PDF]

				S. Mabuchi, M. Ohmichi, A. Kimura, Y. Nishio, E. Arimoto-Ishida, N. Yada-Hashimoto, K. Tasaka, and Y. Murata Estrogen Inhibits Paclitaxel-Induced Apoptosis via the Phosphorylation of Apoptosis Signal-Regulating Kinase 1 in Human Ovarian Cancer Cell Lines Endocrinology, January 1, 2004; 145(1): 49 - 58. [Abstract] [Full Text] [PDF]

				A. Harding, N. Giles, A. Burgess, J. F. Hancock, and B. G. Gabrielli Mechanism of Mitosis-specific Activation of MEK1 J. Biol. Chem., May 2, 2003; 278(19): 16747 - 16754. [Abstract] [Full Text] [PDF]

				A. Anelli, R. R. Brentani, A. P. Gadelha, A. Amorim de Albuquerque, and F. Soares Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer Ann. Onc., March 1, 2003; 14(3): 428 - 432. [Abstract] [Full Text] [PDF]

				L. Drew, R. L. Fine, T. N. Do, G. P. Douglas, and D. P. Petrylak The Novel Antimicrotubule Agent Cryptophycin 52 (LY355703) Induces Apoptosis via Multiple Pathways in Human Prostate Cancer Cells Clin. Cancer Res., December 1, 2002; 8(12): 3922 - 3932. [Abstract] [Full Text] [PDF]

				J.-i. Sasaki, R. Ramesh, S. Chada, Y. Gomyo, J. A. Roth, and T. Mukhopadhyay The Anthelmintic Drug Mebendazole Induces Mitotic Arrest and Apoptosis by Depolymerizing Tubulin in Non-Small Cell Lung Cancer Cells Mol. Cancer Ther., November 1, 2002; 1(13): 1201 - 1209. [Abstract] [Full Text] [PDF]

				S. Mabuchi, M. Ohmichi, A. Kimura, K. Hisamoto, J. Hayakawa, Y. Nishio, K. Adachi, K. Takahashi, E. Arimoto-Ishida, Y. Nakatsuji, et al. Inhibition of Phosphorylation of BAD and Raf-1 by Akt Sensitizes Human Ovarian Cancer Cells to Paclitaxel J. Biol. Chem., August 30, 2002; 277(36): 33490 - 33500. [Abstract] [Full Text] [PDF]

				Y. Huang and W. Fan Ikappa B Kinase Activation Is Involved in Regulation of Paclitaxel-Induced Apoptosis in Human Tumor Cell Lines Mol. Pharmacol., January 1, 2002; 61(1): 105 - 113. [Abstract] [Full Text] [PDF]

				S. A. Holstein and R. J. Hohl Synergistic Interaction of Lovastatin and Paclitaxel in Human Cancer Cells Mol. Cancer Ther., December 1, 2001; 1(2): 141 - 149. [Abstract] [Full Text] [PDF]

				R. Kwan, J. Burnside, T. Kurosaki, and G. Cheng MEKK1 Is Essential for DT40 Cell Apoptosis in Response to Microtubule Disruption Mol. Cell. Biol., November 1, 2001; 21(21): 7183 - 7190. [Abstract] [Full Text] [PDF]

				P. N. Munster, A. Basso, D. Solit, L. Norton, and N. Rosen Modulation of Hsp90 Function by Ansamycins Sensitizes Breast Cancer Cells to Chemotherapy-induced Apoptosis in an RB- and Schedule-dependent Manner : See The Biology Behind: E. A. Sausville, Combining Cytotoxics and 17-Allylamino, 17-Demethoxygeldanamycin: Sequence and Tumor Biology Matters. Clin. Cancer Res., 7: 2155-2158, 2001. Clin. Cancer Res., August 1, 2001; 7(8): 2228 - 2236. [Abstract] [Full Text] [PDF]

				Y. Mitsuuchi, S. W. Johnson, M. Selvakumaran, S. J. Williams, T. C. Hamilton, and J. R. Testa The Phosphatidylinositol 3-Kinase/AKT Signal Transduction Pathway Plays a Critical Role in the Expression of p21WAF1/CIP1/SDI1 Induced by Cisplatin and Paclitaxel Cancer Res., October 1, 2000; 60(19): 5390 - 5394. [Abstract] [Full Text]

				C. Shelly, L. Petruzzelli, and R. Herrera K562 Cells Resistant to Phorbol 12-Myristate 13-acetate-induced Growth Arrest: Dissociation of Mitogen-activated Protein Kinase Activation and Egr-1 Expression from Megakaryocyte Differentiation Cell Growth Differ., September 1, 2000; 11(9): 501 - 506. [Abstract] [Full Text]

				C.-P. H. Yang and S. B. Horwitz Taxol Mediates Serine Phosphorylation of the 66-kDa Shc Isoform Cancer Res., September 1, 2000; 60(18): 5171 - 5178. [Abstract] [Full Text]

				S. Zeng, Y. Z. Chen, L. Fu, K. R. Johnson, and W. Fan In Vitro Evaluation of Schedule-dependent Interactions between Docetaxel and Doxorubicin against Human Breast and Ovarian Cancer Cells Clin. Cancer Res., September 1, 2000; 6(9): 3766 - 3773. [Abstract] [Full Text]

				Y. Huang, K. R. Johnson, J. S. Norris, and W. Fan Nuclear Factor-{{kappa}}B/I{{kappa}}B Signaling Pathway May Contribute to the Mediation of Paclitaxel-induced Apoptosis in Solid Tumor Cells Cancer Res., August 1, 2000; 60(16): 4426 - 4432. [Abstract] [Full Text]

				S. J. Chmura, M. E. Dolan, A. Cha, H. J. Mauceri, D. W. Kufe, and R. R. Weichselbaum In Vitro and in Vivo Activity of Protein Kinase C Inhibitor Chelerythrine Chloride Induces Tumor Cell Toxicity and Growth Delay in Vivo Clin. Cancer Res., February 1, 2000; 6(2): 737 - 742. [Abstract] [Full Text]

				D. R. Gandara, E. Vokes, M. Green, P. Bonomi, R. Devore, R. Comis, D. Carbone, D. Karp, and C. Belani Activity of Docetaxel in Platinum-Treated Non-Small-Cell Lung Cancer: Results of a Phase II Multicenter Trial J. Clin. Oncol., January 5, 2000; 18(1): 131 - 131. [Abstract] [Full Text] [PDF]

				K. R. Johnson, K. K. Young, and W. Fan Antagonistic Interplay between Antimitotic and G1-S Arresting Agents Observed in Experimental Combination Therapy Clin. Cancer Res., September 1, 1999; 5(9): 2559 - 2565. [Abstract] [Full Text] [PDF]

				B. Kurdoglu, N. Cheong, J. Guan, B. W. Corn, W. J. Curran Jr., and G. Iliakis Apoptosis as a Predictor of Paclitaxel-induced Radiosensitization in Human Tumor Cell Lines Clin. Cancer Res., September 1, 1999; 5(9): 2580 - 2587. [Abstract] [Full Text] [PDF]

				Z. A. Stewart, D. Mays, and J. A. Pietenpol Defective G1-S Cell Cycle Checkpoint Function Sensitizes Cells to Microtubule Inhibitor-induced Apoptosis Cancer Res., August 1, 1999; 59(15): 3831 - 3837. [Abstract] [Full Text] [PDF]

				C. Dumontet and B. I. Sikic Mechanisms of Action of and Resistance to Antitubulin Agents: Microtubule Dynamics, Drug Transport, and Cell Death J. Clin. Oncol., March 1, 1999; 17(3): 1061 - 1061. [Abstract] [Full Text] [PDF]

				M. Muller, S. Wilder, D. Bannasch, D. Israeli, K. Lehlbach, M. Li-Weber, S. L. Friedman, P. R. Galle, W. Stremmel, M. Oren, et al. p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs J. Exp. Med., December 7, 1998; 188(11): 2033 - 2045. [Abstract] [Full Text] [PDF]

				C. D. Scatena, Z. A. Stewart, D. Mays, L. J. Tang, C. J. Keefer, S. D. Leach, and J. A. Pietenpol Mitotic Phosphorylation of Bcl-2 during Normal Cell Cycle Progression and Taxol-induced Growth Arrest J. Biol. Chem., November 13, 1998; 273(46): 30777 - 30784. [Abstract] [Full Text] [PDF]

				Y.-H. Ling, C. Tornos, and R. Perez-Soler Phosphorylation of Bcl-2 Is a Marker of M Phase Events and Not a Determinant of Apoptosis J. Biol. Chem., July 24, 1998; 273(30): 18984 - 18991. [Abstract] [Full Text] [PDF]

				T.-H. Wang, H.-S. Wang, H. Ichijo, P. Giannakakou, J. S. Foster, T. Fojo, and J. Wimalasena Microtubule-interfering Agents Activate c-Jun N-terminal Kinase/Stress-activated Protein Kinase through Both Ras and Apoptosis Signal-regulating Kinase Pathways J. Biol. Chem., February 27, 1998; 273(9): 4928 - 4936. [Abstract] [Full Text] [PDF]

				M. T. Hartsough, R. S. Frey, P. A. Zipfel, A. Buard, S. J. Cook, F. McCormick, and K. M. Mulder Altered Transforming Growth Factor beta Signaling in Epithelial Cells when Ras Activation Is Blocked J. Biol. Chem., September 13, 1996; 271(37): 22368 - 22375. [Abstract] [Full Text] [PDF]

				M. Fan, M. Goodwin, T. Vu, C. Brantley-Finley, W. A. Gaarde, and T. C. Chambers Vinblastine-induced Phosphorylation of Bcl-2 and Bcl-XL Is Mediated by JNK and Occurs in Parallel with Inactivation of the Raf-1/MEK/ERK Cascade J. Biol. Chem., September 22, 2000; 275(39): 29980 - 29985. [Abstract] [Full Text] [PDF]